Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Pfizer Inc. (PFE)

36.7   -0.05 (-0.14%) 01-17 17:30
Open: 36.68 Pre. Close: 36.75
High: 36.78 Low: 36.4
Volume: 33,009,360 Market Cap: 203,993M
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; a material transfer and collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; and a multi-target drug discovery collaboration with Sosei Group Corporation. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 36.835 - 37.093 37.093 - 37.29
Low: 35.717 - 36.071 36.071 - 36.343
Close: 36.211 - 36.69 36.69 - 37.057

Technical analysis

as of: 2021-01-15 4:44:10 PM
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 46.66     One year: 49.31
Support: Support1: 36.27    Support2: 30.18
Resistance: Resistance1: 39.95    Resistance2: 42.22
Pivot: 37.00
Moving Average: MA(5): 37.05     MA(20): 37.11
MA(100): 36.23     MA(250): 34.90
MACD: MACD(12,26): -0.29     Signal(9): -0.24
Stochastic oscillator: %K(14,3): 32.05     %D(3): 44.63
RSI: RSI(14): 43.16
52-week: High: 43.08  Low: 26.45  Change(%): -4.1
Average Vol(K): 3-Month: 4694919  10-Days: 3416366

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PFE has closed above bottom band by 22.5%. Bollinger Bands are 68.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to PFE's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 15 Jan 2021
Pfizer Inc. stock outperforms market despite losses on the day - MarketWatch

Wed, 13 Jan 2021
Pfizer Inc. stock falls Wednesday, underperforms market - MarketWatch

Tue, 12 Jan 2021
Pfizer Drops After 2021 Earnings Forecast Trails Estimates - Bloomberg

Tue, 12 Jan 2021
Should You Really Invest in Pfizer Stock in 2021? - The Motley Fool

Mon, 11 Jan 2021
Pfizer Inc. stock outperforms market on strong trading day - MarketWatch

Mon, 11 Jan 2021
Pfizer Inc. (PFE) Rises 1.72% for January 11 -

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 5,560
Shares Float (M) 5,550
% Held by Insiders 0.05
% Held by Institutions 69.90
Shares Short (K) 63,140
Shares Short P. Month (K) 66,530

Stock Financials

EPS 1.540
EPS Est This Year 2.560
EPS Est Next Year 2.760
Book Value (p.s.) 11.740
Profit Margin 17.85
Operating Margin 29.24
Return on Assets (ttm) 5.1
Return on Equity (ttm) 13.3
Qtrly Rev. Growth -4.3
Gross Profit (p.s.) 7.507
Sales Per Share 8.750
EBITDA (p.s.) 3.475
Qtrly Earnings Growth -71.40
Operating Cash Flow (M) 12,550
Levered Free Cash Flow (M) -655

Stock Valuations

PE Ratio 23.83
PEG Ratio 5.26
Price to Book value 3.13
Price to Sales 4.19
Price to Cash Flow 16.26

Stock Dividends

Dividend 1.500
Forward Dividend 1.560
Dividend Yield 0.04
Dividend Pay Date 2021-03-04
Ex-Dividend Date 2021-01-27
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.